AstraZeneca Proclaims Promising Long-Acting COVID-19 Antibody

Results For Evusheld Upgrade Due In H2 2023

 
• By Kevin Grogan
  
Mark Esser
Mark Esser • Source: AstraZeneca
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip